Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials - BMC Cardiovascular Disorders Background Dual antiplatelet therapy (DAPT), combining aspirin and a P2Y12 receptor inhibitor, is a standard post-percutaneous coronary intervention (PCI) treatment to reduce thrombosis and ischemic e...

#MetaAnalysis of 40 trials shows ≤3 months of #DualAntiplateletTherapy (aspirin + P2Y12 inhibitor) lowers #mortality and severe #bleeding without raising #HeartAttack or #Stroke risk. #DAPT #PCI #AcuteCoronarySyndrome bmccardiovascdisord.biomedcentral.com/articles/10....